Tenax Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update

Expected in First Half of 2026, with Topline Data Expected in Second Half of 2026 On Track to Initiate Second Phase 3 Study, ...

BioRestorative Therapies Reports Third Quarter 2025 Financial Results and Provides Business ...

BioRestorative Therapies, Inc. (“BioRestorative”, “BRTX” or the “Company”) (NASDAQ:BRTX), a regenerative medicine innovator ...